Page 32 - AN-3-1

Advanced Neurology BTKi in brain diseases

RB. Microglia amplify inflammatory activation of astrocytes doi: 10.1128/microbiolspec.MCHD-0045-2016
in manganese neurotoxicity. J Neuroinflammation. 27. Bence K, Ma W, Kozasa T, Huang XY. Direct stimulation
2017;14(1):99.
of Bruton’s tyrosine kinase by G(q)-protein alpha-subunit.
doi: 10.1186/s12974-017-0871-0 Nature. 1997;389(6648):296-299.
16. Dansokho C, Heneka MT. Neuroinflammatory responses doi: 10.1038/38520
in Alzheimer’s disease. J Neural Transm (Vienna). 28. Bournazos S, Ravetch JV. Fcγ receptor pathways
2017;125(5):771-779. during active and passive immunization. Immunol Rev.
doi: 10.1007/s00702-017-1831-7 2015;268(1):88-103.
17. Montalban X, Arnold DL, Weber MS, et al. Placebo- doi: 10.1111/imr.12343
controlled trial of an oral BTK inhibitor in multiple sclerosis. 29. Di Paolo JA, Huang T, Balazs M, et al. Specific Btk inhibition
N Engl J Med. 2019;380(25):2406-2417. suppresses B cell- and myeloid cell-mediated arthritis. Nat
doi: 10.1056/NEJMoa1901981 Chem Biol. 2011;7(1):41.
18. Dal Porto J. B cell antigen receptor signaling 101. Mol doi: 10.1038/nchembio.481
Immunol. 2004;41(6-7):599-613. 30. Zhang Y, Sloan Steven A, Clarke Laura E, et al. Purification
doi: 10.1016/j.molimm.2004.04.008 and characterization of progenitor and mature human
astrocytes reveals transcriptional and functional differences
19. McDonald C, Xanthopoulos C, Kostareli E. The role of with mouse. Neuron. 2016;89(1):37-53.
Bruton’s tyrosine kinase in the immune system and disease.
Immunology. 2021;164(4):722-736. doi: 10.1016/j.neuron.2015.11.013
doi: 10.1111/imm.13416 31. de Gorter DJ, Beuling EA, Kersseboom R, et al. Bruton’s
tyrosine kinase and phospholipase Cgamma2 mediate
20. Gu D, Tang H, Wu J, Li J, Miao Y. Targeting Bruton tyrosine chemokine-controlled B cell migration and homing.
kinase using non-covalent inhibitors in B cell malignancies. Immunity. 2007;261:93-104.
J Hematol Oncol. 2021;14(1):40.
doi: 10.1016/j.immuni.2006.11.012
doi: 10.1186/s13045-021-01049-7
32. Li N, Jiang P, Chen A, et al. CX3CR1 positively regulates
21. Zhang D, Gong H, Meng F. Recent advances in BTK BCR signaling coupled with cell metabolism via
inhibitors for the treatment of inflammatory and negatively controlling actin remodeling. Cell Mol Life Sci.
autoimmune diseases. Molecules. 2021;26(16):4907. 2020;77(21):4379-4395.
doi: 10.3390/molecules26164907 doi: 10.1007/s00018-019-03416-7
22. Weber ANR, Bittner Z, Liu X, Dang TM, Radsak MP, 33. Wang M L, Rule S, Martin P, et al. Targeting BTK with
Brunner C. Bruton’s tyrosine kinase: An emerging key ibrutinib in relapsed or refractory mantle-cell lymphoma. N
player in innate immunity. Front Immunol. 2017;8:1454. Engl J Med. 2013;369(6):507-516.

doi: 10.3389/fimmu.2017.01454 doi: 10.1056/NEJMoa1306220
23. Doyle SL, Jefferies CA, Feighery C, O’Neill LAJ. Signaling by 34. Byrd JC, Furman RR, Coutre SE, et al. Targeting BTK with
toll-like receptors 8 and 9 requires Bruton’s tyrosine kinase. ibrutinib in relapsed chronic lymphocytic leukemia. N Engl
J Biol Chem. 2007;282(51):36953-36960. J Med. 2013;369(1):32-42.
doi: 10.1074/jbc.M707682200 doi: 10.1056/NEJMoa1215637
24. Chang BY, Huang M, Francesco M, et al. The Bruton tyrosine 35. Cetin A, Komai S, Eliava M, Seeburg PH, Osten P.
kinase inhibitor PCI-32765 ameliorates autoimmune Stereotaxic gene delivery in the rodent brain. Nat Protoc.
arthritis by inhibition of multiple effector cells. Arthritis Res 2006;1(6):3166-3173.
Ther. 2011;13(4):R115.
doi: 10.1038/nprot.2006.450
doi: 10.1186/ar3400
36. Honigberg LA, Smith AM, Sirisawad M, et al. The
25. Fiorcari S, Maffei R, Audrito V, et al. Ibrutinib modifies the Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell
function of monocyte/macrophage population in chronic activation and is efficacious in models of autoimmune
lymphocytic leukemia. Oncotarget. 2016;7(40):65968-65981. disease and B-cell malignancy. Proc Natl Acad Sci U S A.
doi: 10.18632/oncotarget.11782 2010;107(29):13075-13080.
doi: 10.1073/pnas.1004594107
26. Bournazos S, Wang TT, Ravetch JV. The role and function
of Fcγ receptors on myeloid cells. Microbiol Spectr. 37. Liu Y, Given KS, Owens GP, Macklin WB, Bennett JL.
2016;4(6):10. Distinct patterns of glia repair and remyelination in antibody-

Volume 3 Issue 1 (2024) 8 https://doi.org/10.36922/an.2184